Loading issuer details...
How Green Cross Health Limited makes money — FY2026
Revenue $546.0m · EBITDA $50.4m (9.2% of revenue) · Net profit $25.9m (4.7% of revenue)
Band widths are proportional to NZD amounts. Dashed outlines mark derived figures; the hatched node is a balancing item (net profit less every line above it).
| FY2026 | Amount | Status | Note |
|---|---|---|---|
| Revenue | $546.0m | Reported | |
| Operating costs (net of other income) | −$495.6m | Derived * | Reported operating expenses $482.3m do not reconcile; not used. |
| EBITDA | $50.4m | Derived * | |
| Depreciation & amortisation | −$5.2m | Reported | |
| EBIT | $45.3m | Reported | |
| Interest (net finance costs) | −$1.6m | Reported | |
| Income tax | −$9.9m | Reported | |
| Other items (net cost) | −$7.9m | Balancing item * | Net profit less the lines above; covers fair-value movements, impairments, associates and anything else not itemised. |
| Net profit | $25.9m | Reported |
- * ebitda: $50.4m = EBIT + depreciation & amortisation
- * operating costs: $495.6m = Revenue − EBITDA
Figures extracted automatically from the annual report; check against the report. NZD thousands as stored, shown in millions. Source: annual_report_pdf · method: claude_haiku_pdf · extracted 5 September 2026.
Annual report: Green Cross Health Limited 2026 Annual Report (PDF, NZX)
Green Cross Health Limited board of directors
8 current directors, 38% independent, average tenure 9.9 years.
| Director | Role | Independent | Appointed | Tenure | Committees |
|---|---|---|---|---|---|
| Kim Ellis | Chair | No | 2019 | 6.9 yrs | — |
| Catherine Treneman | Independent Director | Yes | 2025 | 1.1 yrs | — |
| Rachael Newfield | Executive Director | No | 2019 | 7.7 yrs | — |
| Craig Brockliss | Non-Independent Director | No | 2022 | 4.5 yrs | — |
| Peter Merton | Non-Independent Director | No | 2021 | 5.1 yrs | — |
| John Andrew Bagnall | Independent Director | Yes | 2009 | 17.2 yrs | — |
| John Bolland | Non-Independent Director | No | 2007 | 19.1 yrs | — |
| Kenneth Orr | Independent Director | Yes | 2009 | 17.8 yrs | — |
GXH governance score breakdown
Green Cross Health Limited scores 73/100 (Good) on the NZXplorer Governance Risk Score for FY2026, based on 63% data coverage. See the GRS methodology.
- Board structure
- 14/25
- Shareholder rights
- 20/20
- Executive remuneration
- 0/0
GXH dividends
The most recent Green Cross Health Limited dividend on record is 5.50 cents per share, for FY2026 (final), 100% imputed, ex-dividend 5 Jun 2026, paid 22 Jun 2026.
Green Cross Health Limited largest shareholders
Top 3 registered holders of GXH as disclosed for FY2025. Registry holdings include custodians and nominees, which may hold on behalf of many underlying investors.
| # | Holder | Holding |
|---|---|---|
| 1 | LPL TRUSTEE LIMITED | 31.96% |
| 2 | CAPE HEALTHCARE LIMITED | 31.90% |
| 3 | WILTON ASSET MANAGEMENT LTD | 8.76% |
Recent GXH NZX announcements
The 10 most recent filings by Green Cross Health Limited to the NZX.
- Green Cross Health – substantial holding disclosureInsider/Shareholder Notice
- Appointment of Chief Executive OfficerOther
- Green Cross Health Limited (GXH) CEO ResignationDirector Departure
- Completion of Sale of Green Cross Health’s Medical DivisionM&A
- D&O ongoing disclosureInsider Disclosure
- GXH: Annual Shareholders’ Meeting: ResultsAGM
- GXH: Annual Shareholders’ Meeting: Speeches & PresentationAGM
- Green Cross Health Limited - Annual Shareholders' MeetingAGM
- Revised Annual Meeting DateAGM
- Green Cross Health Limited 2026 Annual ReportAnnual Report
Green Cross Health Limited (GXH) — frequently asked questions
What does Green Cross Health Limited do?
Green Cross Health operates New Zealand's largest pharmacy network under the Life Pharmacy and Unichem brands, plus medical centres and community health services. Green Cross Health Limited is listed on the NZX under the ticker GXH, in the Healthcare sector.
What is the Green Cross Health Limited (GXH) share price?
Green Cross Health Limited (NZX:GXH) shares closed at $1.93 on 22 October 2026, up 0.52% on the previous close. At that price its market capitalisation was about $278 million, based on 143,834,147 shares on issue.
Who are the directors of Green Cross Health Limited?
Green Cross Health Limited has 8 current directors: Kim Ellis (Chair), Catherine Treneman (Independent Director), Rachael Newfield (Executive Director), Craig Brockliss (Non-Independent Director), Peter Merton (Non-Independent Director), John Andrew Bagnall (Independent Director), John Bolland (Non-Independent Director) and Kenneth Orr (Independent Director). 3 of the 8 are recorded as independent (38%). Average board tenure is 9.9 years.
Who is the chair of Green Cross Health Limited?
Kim Ellis chairs the Green Cross Health Limited board, and has been a director since 2019.
What was Green Cross Health Limited's most recent dividend?
The most recent Green Cross Health Limited dividend on record is 5.50 cents per share for FY2026 (final), 100% imputed, ex-dividend 5 June 2026, paid 22 June 2026.
What is Green Cross Health Limited's dividend yield?
Green Cross Health Limited's trailing 12-month dividend yield is 4.40%, as at 22 October 2026. That is 8.50 cents per share of ordinary dividends with an ex-date in the 12 months to 22 October 2026, divided by the 22 October 2026 closing price of $1.93. Special dividends are excluded.
Who are the largest shareholders of Green Cross Health Limited?
The largest registered holder of GXH shares in the FY2025 top-20 register was LPL TRUSTEE LIMITED, with 31.96%, followed by CAPE HEALTHCARE LIMITED (31.90%) and WILTON ASSET MANAGEMENT LTD (8.76%).
What is Green Cross Health Limited's governance score?
Green Cross Health Limited has an NZXplorer Governance Risk Score of 73/100 (Good) for FY2026, based on 63% data coverage.
When was the last Green Cross Health Limited annual meeting?
The most recent Green Cross Health Limited annual meeting on record was held on 31 July 2026.
Healthcare companies on the NZX
Compare Green Cross Health Limited with other NZX-listed healthcare companies.